Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety, tolerability, and effectiveness of LX3305
versus a placebo control in subjects with active rheumatoid arthritis on stable methotrexate
therapy.